Literature DB >> 31839246

Neuromyelitis optica in patients with increased interferon alpha concentrations.

Jac Williams1, Sarah McGlasson2, Sarosh Irani3, Darragh Duffy4, Yanick Crow2, David Hunt5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31839246     DOI： 10.1016/S1474-4422(19)30445-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   59.935


× No keyword cloud information.
  4 in total

1.  SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.

Authors:  Lennard Ostendorf; Philipp Dittert; Robert Biesen; Ankelien Duchow; Victoria Stiglbauer; Klemens Ruprecht; Judith Bellmann-Strobl; Dominik Seelow; Werner Stenzel; Raluca A Niesner; Anja E Hauser; Friedemann Paul; Helena Radbruch
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

2.  Fulminant Course of Neuromyelitis Optica in a Patient With Anti-MDA5 Antibody-Positive Dermatomyositis: A Case Report.

Authors:  You-Ri Kang; Kun-Hee Kim; Tai-Seung Nam; Kyung-Hwa Lee; Kyung Wook Kang; Seung-Jin Lee; Seok-Yong Choi; Gopalakrishnan Chandrasekaran; Myeong-Kyu Kim
Journal:  Front Med (Lausanne)       Date:  2020-11-11

3.  B-Cell Compartmental Features and Molecular Basis for Therapy in Autoimmune Disease.

Authors:  Chao Zhang; Tian-Xiang Zhang; Ye Liu; Dongmei Jia; Pei Zeng; Chen Du; Meng Yuan; Qiang Liu; Yongjun Wang; Fu-Dong Shi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-31

4.  Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder.

Authors:  Jie Rao; Na Xu; Jing Sun; Yan Li; Fangwang Fu
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.